Locally ablative treatment of breast cancer liver metastases: identification of factors influencing survival (the Mammary Cancer Microtherapy and Interventional Approaches (MAMMA MIA) study)

Table 2 Treatment characteristics (59 patients)

Chemotherapy prior to interventional LMBC treatment (without hormones)		92 % (n = 54)
	median number of applied lines (range)	2 (0 - 8)
Local treatment of breast cancer metastases prior to interventional LMBC treatment, overall		68 % (n = 40)
	surgery (for metastasis)^a	n = 19
	radiotherapy^a	n = 20
Bisphophonates prior to interventional LMBC treatment		n = 24
Concomitant or subsequent breast cancer therapy (after initiation of interventional LMBC treatment), overall		86 % (n = 51)
	chemotherapy^a	n = 40
	hormones^a	n = 22
	surgery^a	n = 7
	radiotherapy^a	n = 14
Total number of interventional procedures for LMBC^a		n = 97
	interstitial brachytherapy (BT)	n = 68
	radioembolization (RE)	n = 34
	radiofrequency ablation (RFA)	n = 5
Number of interventional procedures per patient (1/2/3/4/5/6/7) (n)		(37/13/5/0/2/1/1)
First treatment per patient (BT/RE/RFA/combination) (n)		(29/22/3/5)
Treatment modalities per patient (first and all subsequent procedures)
	RE only	n = 17
	BT only	n = 25
	RFA only	n = 1
	BT and RE	n = 12
	BT and RFA	n = 3
	RE and RFA	n = 1

ISSN: 1471-2407